- Report
- November 2021
- 234 Pages
Global
From €3663EUR$4,000USD£3,119GBP
- Report
- December 2023
- 22 Pages
Global
From €2290EUR$2,500USD£1,949GBP
- Report
- January 2024
- 163 Pages
Global
From €4533EUR$4,950USD£3,860GBP
- Report
- May 2025
Asia Pacific
From €1919EUR$2,095USD£1,634GBP
€3654EUR$3,990USD£3,111GBP
- Report
- May 2025
Asia Pacific
From €1919EUR$2,095USD£1,634GBP
€3654EUR$3,990USD£3,111GBP
- Report
- January 2025
- 132 Pages
Global
From €870EUR$950USD£741GBP
- Report
- January 2025
- 132 Pages
Global
From €870EUR$950USD£741GBP
- Report
- January 2025
- 132 Pages
Global
From €870EUR$950USD£741GBP
- Report
- January 2025
- 132 Pages
Global
From €870EUR$950USD£741GBP
- Report
- January 2025
- 132 Pages
Global
From €870EUR$950USD£741GBP
- Report
- January 2025
- 132 Pages
Global
From €870EUR$950USD£741GBP
- Report
- January 2025
- 132 Pages
Global
From €870EUR$950USD£741GBP
- Report
- January 2025
- 132 Pages
Global
From €870EUR$950USD£741GBP
- Report
- January 2025
- 132 Pages
Global
From €870EUR$950USD£741GBP
- Report
- January 2025
- 132 Pages
Global
From €870EUR$950USD£741GBP
- Report
- January 2025
- 132 Pages
Global
From €870EUR$950USD£741GBP

Severe Acute Respiratory Syndrome (SARS) is a contagious respiratory illness caused by a virus. Diagnostics for SARS involve laboratory tests to detect the virus or its genetic material in a sample taken from the patient. Diagnostic tests for SARS include reverse transcription-polymerase chain reaction (RT-PCR), antigen-capture enzyme-linked immunosorbent assay (ELISA), and nucleic acid hybridization. These tests are used to detect the presence of the virus in a patient's sample and to differentiate between SARS and other respiratory illnesses.
Diagnostics for SARS are important for early detection and treatment of the disease. Early diagnosis and treatment can reduce the severity of the illness and prevent its spread. Diagnostics for SARS are also used to monitor the spread of the virus and to track its evolution.
Companies in the SARS diagnostics market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, and Roche Diagnostics. Show Less Read more